House Energy and Commerce Committee

Rep. Tom Price Purchases Discounted Healthcare Stocks While Drafting Industry Legislation

| Importance: 9/10

On August 31, 2016, Rep. Tom Price (R-GA), chairman of the House Budget Committee and member of the Ways and Means Health Subcommittee, purchased between $50,001 and $100,000 in discounted shares of Innate Immunotherapeutics, an Australian biotech company, through a private placement offering …

Tom Price Chris Collins Innate Immunotherapeutics Zimmer Biomet House Energy and Commerce Committee insider-trading congressional-corruption healthcare revolving-door stock-act-violation +2 more
Read more →

Energy Committee Hearings Expose Oil Industry Climate Denial Campaign and Regulatory Capture

| Importance: 8/10

Documents revealed that Vice President Dick Cheney’s Energy Task Force had met extensively with executives from major oil companies, though chief executives denied involvement when testifying before the Senate Energy and Commerce committees. The revelation exposed how the Energy and Commerce …

House Energy and Commerce Committee Dick Cheney ExxonMobil American Petroleum Institute regulatory-capture climate-change oil-industry lobbying congressional-corruption
Read more →

Medicare Part D Passes After Pharmaceutical Industry Writes Price Negotiation Ban

| Importance: 9/10

The House of Representatives passed the Medicare Prescription Drug, Improvement, and Modernization Act at 5:53 AM after an unprecedented 3-hour vote that House leaders held open for nearly three hours past the normal 15-minute voting period to secure enough votes. The legislation created Medicare …

Billy Tauzin House Energy and Commerce Committee PhRMA Medicare regulatory-capture healthcare pharmaceutical-industry congressional-corruption lobbying
Read more →